Mentor Investigation Does Not Involve Breast Implant PMA Data, Firm Says
This article was originally published in The Gray Sheet
Executive Summary
Conversations between Mentor Corp. and FDA's Office of Criminal Investigations have not "related in any way to our research or our [clinical] studies" of saline-filled breast implants, Mentor President and CEO Anthony Gette reported at a March 23 teleconference.
You may also be interested in...
Energy & Commerce Looking To Include Breast Implant Bill In Device Package
The House Energy & Commerce/Oversight & Investigations Subcommittee is requesting that FDA deliver all documents related to a criminal investigation of Mentor by Oct. 9
Energy & Commerce Looking To Include Breast Implant Bill In Device Package
The House Energy & Commerce/Oversight & Investigations Subcommittee is requesting that FDA deliver all documents related to a criminal investigation of Mentor by Oct. 9
FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
Mentor and Inamed should reconvene focus groups to review patient labeling changes for saline-filled breast implants, FDA's General and Plastic Surgery Devices Panel recommended July 9 at its meeting in Gaithersburg, Maryland